Home・Elenco Azioni・Novocure Ltd

Novocure Ltd

Chiusa

SettoreSettore sanitario

16.92 -2.48

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

16.64

Massimo

17.36

Metriche Chiave
By Trading Economics
Entrata	55M -16M
Vendite	9.5M 184M
EPS	-0.13
Margine di Profitto	-8.529
Dipendenti	1,605
EBITDA	53M -11M

Raccomandazioni
By TipRanks
Raccomandazioni	Acquista
Previsioni per 12 mesi	+74.04% upside

Dividendi
By Acuity
Utili prossimi	29 ott 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	169M 2B
Apertura precedente	19.4
Chiusura precedente	16.92

Notizie sul Sentiment di mercato

By Acuity

55%

45%

281 / 340 Classifica in Healthcare

Novocure Ltd Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

14 ago 2026, 23:21 UTC

Novocure Ltd shares are higher in after-market trading, reversing a three-session decline. No specific company news was identified to explain this movement.

13 ago 2026, 21:01 UTC

Novocure Ltd. shares are lower in after-market trading, reflecting a shift in sentiment despite being above the 20-day moving average.

12 ago 2026, 19:41 UTC

Novocure Ltd. shares are lower today, reversing a trend of higher daily closes since Tuesday. Earlier in the session, the stock rebounded from a session high.

11 ago 2026, 20:06 UTC

Novocure Ltd's shares are advancing, remaining above the 20-day moving average amid strong momentum. No specific company news has been identified for the price movement.

10 ago 2026, 21:01 UTC

Novocure Ltd shares are higher in after-market trading, supported by strong performance above the 20-day moving average and within the one-month trading range.

8 ago 2026, 00:01 UTC

Novocure Ltd. shares were roughly flat in after-market hours. The stock is near the lower end of its one-month range, despite being above its 20-day average.

7 ago 2026, 23:11 UTC

Novocure Ltd. shares are lower in after-market trading, reflecting a decline since Friday's close and remaining near the lower end of their one-month range.

6 ago 2026, 19:36 UTC

Novocure Ltd. shares are trading lower, reaching a session low and remaining below the 20-day moving average during Thursday's trading session.

5 ago 2026, 19:56 UTC

Novocure Ltd. shares are lower today, trading below their 20-day moving average and near the lower end of their one-month range.

4 ago 2026, 21:02 UTC

Novocure Ltd. shares are lower in after-market trading, continuing a decline since Tuesday's close amid broader market volatility and fluctuating crude oil prices.

3 ago 2026, 20:06 UTC

Novocure Ltd. shares are higher today, reflecting broader market gains amid positive investor sentiment and declines in oil prices.

31 lug 2026, 19:46 UTC

Novocure Ltd. shares are lower today, retracing from earlier session highs amid rising bond yields and ongoing inflation concerns. The stock remains below its 20-day moving average.

30 lug 2026, 19:39 UTC

Novocure Ltd shares are higher today, recovering from an early dip. The stock remains below its 20-day moving average amid a trend of lower closes.

29 lug 2026, 18:55 UTC

Novocure Ltd's shares are declining today, reversing from a recent trend of higher daily closes. Earlier in the session, the stock briefly rebounded.

28 lug 2026, 23:31 UTC

Novocure Ltd. shares are lower in after-market hours, continuing a decline over the past four sessions and trading below the 20-day moving average.

27 lug 2026, 19:06 UTC

Novocure Ltd. shares are lower today amid a broader market decline influenced by a significant drop in crude oil prices.

24 lug 2026, 19:41 UTC

News

Social Media

Novocure Ltd's stock is lower following its Q2 earnings report, despite a narrower loss and revenue beat. Analysts lowered price targets amid ongoing investor concerns.

22 lug 2026, 20:04 UTC

Shares of Novocure Ltd. are lower today, continuing a decline since Tuesday's close amid broader market uncertainty ahead of the Federal Reserve meeting.

20 lug 2026, 14:36 UTC

Novocure Ltd. is trading higher since Friday's close, despite pulling back from an early session high amid broader market volatility from geopolitical tensions.

Confronto tra pari

Modifica del prezzo

Novocure Ltd Previsione

Obiettivo di Prezzo

By TipRanks

74.04% in crescita

Previsioni per 12 mesi

Media 29.5 USD 74.04%

Alto 52 USD

Basso 17 USD

Basato su 4 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Novocure Ltd - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

4 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 4 che hanno fornito valutazioni azionarie a Novocure Ltd - Dist negli ultimi 3 mesi.

Sentiment

By Acuity

281 / 340 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Novocure Ltd

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.